Callos Andrew sold CYTK
December 5, 2025 · Form 4 insider transaction
Callos Andrew sold 52,486 shares of Cytokinetics, Incorporated at $65.95 per share, a transaction worth $3.46M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
52,486
Price
$65.95
Total value
$3.46M
InsiderCallos Andrew
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 5, 2025
Filing dateDecember 5, 2025
Shares owned after50,660
OwnershipDirect
10b5-1 planNo
AmendedNo